TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
- Status
- RECRUITING
- Phase
- PHASE2
HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Serplulimab for Locally Advanced Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
- Status
- RECRUITING
- Phase
- PHASE2